Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022
26 September 2022 - 09:30PM
Business Wire
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
technology marketed and sold as Renuvion®, today announced that
financial results for the third quarter of fiscal year 2022 will be
released before the market opens on Thursday, November 10th.
Management will host a conference call at 8:00 a.m. Eastern Time
on November 10th to discuss the results of the quarter and host a
question and answer session. To listen to the call by phone,
interested parties may dial 877-407-8289 (or 201-689-8341 for
international callers) and provide access code 13733047.
Participants should ask for the Apyx Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=vs7YbvfR.
A telephonic replay will be available approximately two hours
through the following two weeks. The replay can be accessed by
dialing 877-660-6853 for U.S. callers or 201-612-7415 for
international callers and using the replay access code: 13733047.
The webcast will be archived on the Investor Relations section of
the Company’s website.
About Apyx Medical
Corporation:
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Technology
products marketed and sold as Renuvion® in the cosmetic surgery
market and J-Plasma® in the hospital surgical market. Renuvion® and
J-Plasma® offer surgeons a unique ability to provide controlled
heat to tissue to achieve their desired results. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through OEM agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Apyx Medical Corporation website at
www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220926005017/en/
Investor Relations: ICR
Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA
investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From May 2023 to Jun 2023
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Jun 2022 to Jun 2023